What is Daptomycin With Cas 103060-53-3?
Specification
Product Name: | Daptomycin | Batch No. | JL20220811 |
Cas | 103060-53-3 | MF Date | Aug. 11, 2022 |
Packing | 1KG/BAG | Analysis Date | Aug. 11, 2022 |
Quantity | 100KGS | Expiry Date | Aug. 10, 2024 |
ITEM | STANDARD | RESULT | |
Appearance | Light yellow to yellow powder | Conform | |
Odor | Odorless | Conform | |
Assay | ≥95.0% | 97.9% | |
Specific optical rotation | +15.5~+20.5 | +16.8 | |
Clarity ofsolution | Clarified | Clarified | |
PH | 3.0~4.5 | 3.2 | |
Residue on ignition | ≤0.2% | 0.1% | |
Water | ≤5.0% | 2.4% | |
Lactone hydrolysate | ≤0.80% | 0.08% | |
β-isomer | ≤1.5% | 0.1% | |
RS-5/6 | ≤0.80% | 0.06% | |
RS-7 | ≤0.80% | Not detected | |
RS-7a/7b | ≤0.20% | 0.07% | |
Anhydrodaptomycin | ≤2.0% | 0.8% | |
Other individual | ≤0.15% | Not detected | |
Total impurities | ≤5.0% | 1.1% | |
Ethyl alcohol | ≤0.5% | 0.0% | |
Acetic acid | ≤0.5% | Not detected | |
Bacterial endotoxin(EU/mg) | ≤0.28 | <0.28 | |
Aerobic bacteria(cfu/g) | ≤1000 | <10 | |
Mold &yeast(cfu/g) | ≤100 | <10 | |
E.coil | Not detected | Not detected | |
Conclusion | Qualified |
Application
Medical intermediate for the treatment of concurrent skin and skin structure infections caused by some gram-positive and sensitive strains.Packing
1kgs bag or requirement of clients. Keep it away from light at a temperature below 25℃.Daptomycin With Cas 103060-53-3